Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China flag China · Delayed Price · Currency is CNY
19.35
-0.81 (-4.02%)
At close: Jul 30, 2026

Enwei Pharmaceutical Company Description

Enwei Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines and chemical drugs in China.

The company offers drugs in the areas of gynecology, pediatrics, respiratory, stomatology, digestive, cardiovascular, hepatobiliary, and dermatology under the Jieeryin, Haowayou, and Likeshu brands.

It also provides products for cold and fever relief, dental care, warming/nourishing/tonic purposes, and other uses; ointments, suppositories, capsules, effervescent tablets, and antibacterial washes; hygiene products, disinfectants, medical devices, pharmaceutical packaging materials and containers, and daily chemical products; compound preparations, oral liquids and solutions, syrups, and decoctions; and tablets, granules, powders, large honey and water pills, water-honey and concentrated pills, wax pills, and syrups.

In addition, the company engages in medical research and experimental development. Enwei Pharmaceutical Co., Ltd. was founded in 1986 and is based in Chengdu, China.

Enwei Pharmaceutical Co., Ltd.
CountryChina
Founded1986
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,501
CEOYongjiang Xue

Contact Details

Address:
No. 458, Shuanghua Road
Chengdu, 610200
China
Phone86 28 8154 8888
Websiteenwei.com.cn

Stock Details

Ticker Symbol301331
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100005LC7
SIC Code2834

Key Executives

NamePosition
Yongjiang XueChairman and Chief Executive Officer
Xue GangVice Chairman and President
Dawei HuChief Financial Officer, Vice President and Secretary of the Board
Zhuang YanVice President and Director
Lei ChenVice President
Hui NingAccounting Supervisor